PsychoGenics and Evotec AG have entered into a strategic alliance to provide integrated CNS drug discovery solutions to pharmaceutical and biotech companies. The two companies will work together to provide existing and new clients access to their complementary drug discovery platforms for the identification and development of new therapeutics to treat CNS disorders. PsychoGenics’ proprietary behavioral testing platforms are used for the characterization of drugs, the phenotyping of dise...